Ontology highlight
ABSTRACT: Objectives
To more clearly define the landscape of digital medical devices subject to US Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and cybersecurity features in regulated medical devices.Design
We analysed data from publicly available FDA product summaries to understand the frequency and recent time trends of inclusion of software and cybersecurity content in publicly available product information.Setting
The full set of regulated medical devices, approved over the years 2002-2016 included in the FDA's 510(k) and premarket approval databases.Primary and secondary outcome measures
The primary outcome was the share of devices containing sof
SUBMITTER: Stern AD
PROVIDER: S-EPMC6609083 | biostudies-literature | 2019 Jun
REPOSITORIES: biostudies-literature